CTNND2

Chr 5

catenin delta 2

Also known as: GT24, NPRAP

This gene encodes an adhesive junction associated protein of the armadillo/beta-catenin superfamily and is implicated in brain and eye development and cancer formation. The protein encoded by this gene promotes the disruption of E-cadherin based adherens junction to favor cell spreading upon stimulation by hepatocyte growth factor. This gene is overexpressed in prostate adenocarcinomas and is associated with decreased expression of tumor suppressor E-cadherin in this tissue. This gene resides in a region of the short arm of chromosome 5 that is deleted in Cri du Chat syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

OMIMResearchGenerating clinical summary…
LOFmechanismLOEUF 0.10
Clinical SummaryCTNND2
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 164 VUS of 372 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.10LOEUF
pLI 1.000
Z-score 7.21
OE 0.03 (0.010.10)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
2.77Z-score
OE missense 0.70 (0.650.76)
489 obs / 694.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.03 (0.010.10)
00.351.4
Missense OE?0.70 (0.650.76)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 2 / 64.4Missense obs/exp: 489 / 694.7Syn Z: -1.27
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCTNND2-related neurodevelopmental disorderLOFAD

This gene — mechanism propensity

DN
0.3892th %ile
GOF
0.4677th %ile
LOF
0.80top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 73% of P/LP variants are LoF · LOEUF 0.10

Literature Evidence

LOFTurner et al (2015) performed exome sequencing on 13 females with autism and identified 2 missense variants in the CTNND2 gene. To further explore variation in this gene, they sequenced CTNND2 in 362 additional autism families and identified 7 variants (additional observations of the original 2 miss1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 25807484

ClinVar Variant Classifications

372 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic11
VUS164
Likely Benign88
Benign87
Conflicting8
4
Pathogenic
11
Likely Pathogenic
164
VUS
88
Likely Benign
87
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
0
1
0
4
Likely Pathogenic
8
2
1
0
11
VUS
6
152
6
0
164
Likely Benign
0
26
39
23
88
Benign
1
5
71
10
87
Conflicting
8
Total1818511833362

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

105 pathogenic / likely-pathogenic (of 137) ClinVar copy-number / structural variants overlap CTNND2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CTNND2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →